Bottom line
LABU vs TYO: the short answer
LABU (Direxion Daily S&P Biotech Bull 3X ETF) and TYO (Direxion Daily 7-10 Year Treasury Bear 3X ETF) share a meaningful slice of their top holdings — about 47% by weight.
But LABU is far broader, holding 163 positions to 6 for TYO, so beyond the top names it adds exposure TYO doesn't have.
LABU is cheaper at 0.96% vs 1% — a difference of $4.00 a year per $10,000 invested.
Over five years, TYO returned +13.2% a year vs −39.6% for LABU.
Updated Nov 19, 2026
LABU vs TYO side by side
| LABU | TYO | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | Direxion | Direxion |
| Category | Leveraged & Inverse | Leveraged & Inverse |
| Expense ratio | 0.96% | 1% |
| Annual cost per $10k | $96 | $100 |
| 10-yr cost on $10k (prospectus) | $1,178 | $1,384 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +78.7% | −7.7% |
| 5-yr return (annualized) | −39.6% | +13.2% |
| 10-yr return (annualized) | −20.8% | −0.9% |
| Best quarter | +161.5% | +19.8% |
| Worst quarter | −67.4% | −26.8% |
| Net assets (fund) | $494.4M | $12.5M |
| Number of holdings | 163 | 6 |
| Portfolio turnover | 107% | % |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LABU | TYO | Difference |
|---|---|---|---|
| 2025 | +78.7% | −7.7% | +86.4% |
| 2024 | −25.9% | +18.9% | −44.8% |
| 2023 | −13.4% | +0.7% | −14.1% |
| 2022 | −80.3% | +59.4% | −139.7% |
| 2021 | −64.3% | +5.6% | −69.9% |
| 2020 | +74.7% | −27.5% | +102.2% |
| 2019 | +74.6% | −18.6% | +93.2% |
| 2018 | −57.3% | −0.9% | −56.4% |
| 2017 | +148.7% | −9.3% | +158.0% |
| 2016 | −63.0% | −7.7% | −55.4% |
Source: Fund prospectus bar charts
Holdings overlap
7 of LABU's top 25 holdings also appear in TYO's top 6.
| Holding | LABU | TYO |
|---|---|---|
| Dreyfus | 15.86% | 62.27% |
| Goldman Financial | 14.83% | 18.94% |
| N/a | 9.63% | 2.50% |
| N/a | 7.30% | 2.50% |
| Goldman Sachs Liq Es Fd A | 5.35% | 16.61% |
| N/a | 4.85% | 2.50% |
| N/a | 3.87% | 2.50% |
Source: SEC Form N-PORT
LABU top 10
- Dreyfus — 15.86%
- Goldman Financial — 14.83%
- N/a — 9.63%
- N/a — 7.30%
- Goldman Sachs Liq Es Fd A — 5.35%
- N/a — 4.85%
- N/a — 3.87%
- Apogee Therapeutics Inc — 1.11%
- Oruka Therapeutics Inc — 1.03%
- Dianthus Therapeutics Inc — 0.96%
TYO top 10
- Dreyfus — 62.27%
- Goldman Financial — 18.94%
- Goldman Sachs Liq Es Fd A — 16.61%
- N/a — 5.21%
- N/a — 2.70%
- N/a — 2.50%
FAQ
What is the difference between LABU and TYO?
Which is cheaper, LABU or TYO?
Should I own both LABU and TYO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.